Oaktree Acquisition Corp. III Life Sciences (OACCW) P/E Ratio History
Insufficient DataInsufficient historical P/E data to classify valuation. · Data 2026–2026
Loading P/E history...
P/E Ratio Analysis
Compared to the Financial Services sector median P/E of 13.6x, OACCW is roughly in line with its sector peers. The sector includes 783 companies with P/E ratios ranging from 0.0x to 196.5x.
Relative to the broader market, OACCW trades at a notable discount to the S&P 500 median P/E of 24.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our OACCW DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
OACCW Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
OACCW P/E vs Peers
Healthcare and life sciences SPACs peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $151M | 47.4 | - | -76% | |
| $97B | 31.8 | 1.52 | +7% | |
| $86B | 41.4 | - | -29% | |
| $78B | 18.6Lowest | 0.25Best | -1% | |
| $16B | 20.4 | 1.17 | -21% | |
| $41B | 64.2 | 3.74 | -5% | |
| $16B | 34.0 | - | +1779%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
OACCW — Frequently Asked Questions
Quick answers to the most common questions about buying OACCW stock.
What is OACCW's P/E ratio?
Oaktree Acquisition Corp. III Life Sciences (OACCW) trailing twelve-month P/E ratio is 15.1x, based on TTM diluted EPS of N/A. The 5-year average P/E is N/A and the historical range spans N/A to N/A.
Is OACCW stock overvalued or undervalued?
OACCW current P/E: 15.1x. 5-year average P/E: N/A. Percentile: N/A.
Is OACCW stock expensive?
OACCW is fairly valued relative to its own history. The current P/E of 15.1x is near the 5-year average of N/A (N/A percentile of historical range).
What is OACCW's historical P/E range?
Over the past 5 years, OACCW's P/E ratio has ranged from N/A to N/A, with a median of N/A and an average of N/A. The current P/E of 15.1x places the stock at the N/A percentile of this range. Full historical data spans 2026–2026.
How does OACCW's P/E compare to the S&P 500?
OACCW trades at 15.1x P/E versus the S&P 500 median of 24.3x. The 38% discount to the market suggests lower growth expectations or perceived higher risk.
How does OACCW's valuation compare to Financial Services peers?
Oaktree Acquisition Corp. III Life Sciences P/E of 15.1x compares to the Financial Services sector median of 13.6x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is OACCW's PEG ratio?
OACCW PEG ratio is N/A. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is OACCW's earnings yield?
OACCW earnings yield is 6.61%, the inverse of its 15.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.